Saliva as a Diagnostic Tool in Oral Squamous Cell Carcinoma - a Systematic Review with Meta Analysis.
Biomarkers, Tumor
/ analysis
Chemokines
/ analysis
Early Detection of Cancer
/ methods
Humans
Intercellular Signaling Peptides and Proteins
/ analysis
Matrix Metalloproteinase 9
/ analysis
Mouth Neoplasms
/ diagnosis
Saliva
/ chemistry
Sensitivity and Specificity
Squamous Cell Carcinoma of Head and Neck
/ diagnosis
Chemerin
MMP-9
Markers
Saliva
Journal
Pathology oncology research : POR
ISSN: 1532-2807
Titre abrégé: Pathol Oncol Res
Pays: Switzerland
ID NLM: 9706087
Informations de publication
Date de publication:
Apr 2019
Apr 2019
Historique:
received:
22
08
2018
accepted:
15
01
2019
pubmed:
4
2
2019
medline:
14
6
2019
entrez:
4
2
2019
Statut:
ppublish
Résumé
Whole saliva is mainly composed of fluid produced by major and minor salivary glands. Major salivary glands including parotid, submandibular, and sublingual glands, are known to secrete fluid transported from serum as well as surrounding glandular tissues [1]. Beside the secretions from salivary glands, oral mucosa, periodontium, as well as oral microflora also contribute to the final content of whole saliva [1]. Whole saliva therefore represents a complex balance among local and systemic sources [2]. This allows for the application of saliva in the diagnosis not only for salivary gland disorders but also for oral diseases and systemic conditions [2]. The role of saliva as a diagnostic tool in detecting Oral Squamous Cell Carcinoma. Articles published in PUBMED, EMBASE, COCHRANE, GOOGLE, manual search and back references of the articles for last 5 years extracted 77 articles. Studies which considered saliva as a diagnostic tool were included. Statistical analysis with Receivers Operating Curve to establish sensitivity and specificity of the salivary biomarkers as a diagnostic tool to detect Oral Squamous Cell Carcinoma were included for meta analysis. The measure of effect with 95% confidence interval were meta analysed for 9 articles in which 308 healthy individuals compared with 340 patients with Oral Squamous Cell Carcinoma. Highly sensitive salivary biomarkers for detecting Oral Squamous Cell Carcinoma were MMP-9, Chemerin, Choline + Betaine + Pipecolinic Acid + I - Carnitine(confidence interval ranges from 0.83-1.0). The narrow confidence interval of 0.95 + (0.88-1.00) was seen for MMP-9 followed by 1.00 + (0.78-1.00) for chemerin. Highly specific biomarkers for Oral Squamous Cell Carcinoma were MMP-9 (specificity -100%,), Chemerin(specificity-100%), over expressed mi RNA 136 with specificity of 0.88(0.69-0.97), under expressed mi RNA 27B with specificity of 1.0(0.66-1.00). Saliva can be used as a diagnostic tool with highly sensitive and specific markers namely MMP-9, Chemerin for early detection of Oral Squamous Cell Carcinoma.
Identifiants
pubmed: 30712193
doi: 10.1007/s12253-019-00588-2
pii: 10.1007/s12253-019-00588-2
doi:
Substances chimiques
Biomarkers, Tumor
0
Chemokines
0
Intercellular Signaling Peptides and Proteins
0
RARRES2 protein, human
0
MMP9 protein, human
EC 3.4.24.35
Matrix Metalloproteinase 9
EC 3.4.24.35
Types de publication
Journal Article
Meta-Analysis
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
447-453Références
Jpn J Cancer Res. 1999 Aug;90(8):858-66
pubmed: 10543258
Proc Natl Acad Sci U S A. 2004 Mar 2;101(9):2999-3004
pubmed: 14973191
J Nutr. 2006 Jan;136(1 Suppl):237S-42S
pubmed: 16365090
J Proteome Res. 2007 Dec;6(12):4549-55
pubmed: 17970587
Biomarkers. 2010 Sep;15(6):475-87
pubmed: 20450335
Dent Clin North Am. 2011 Jan;55(1):159-78
pubmed: 21094724
Int J Cancer. 2011 Nov 1;129(9):2207-17
pubmed: 21190195
CA Cancer J Clin. 2011 Mar-Apr;61(2):69-90
pubmed: 21296855
OMICS. 2011 Jun;15(6):353-61
pubmed: 21568728
Cytokine Growth Factor Rev. 2011 Aug;22(4):189-95
pubmed: 22019906
Clin Oral Investig. 2014 Apr;18(3):997-1004
pubmed: 23868294
Clin Chim Acta. 2014 Jan 1;427:79-85
pubmed: 24144867
Oral Dis. 2015 Jan;21(1):90-6
pubmed: 24304502
Talanta. 2014 Feb;119:299-305
pubmed: 24401418
J Dent Res. 2014 Jul;93(7 Suppl):86S-93S
pubmed: 24718111
Oral Surg Oral Med Oral Pathol Oral Radiol. 2014 Sep;118(3):309-19
pubmed: 24950604
Proc Natl Acad Sci U S A. 2015 Mar 10;112(10):E1106-15
pubmed: 25713380
Oncol Rep. 2015 May;33(5):2161-8
pubmed: 25761055
Oral Dis. 2015 Sep;21(6):739-47
pubmed: 25784212
World J Surg Oncol. 2015 Aug 21;13:253
pubmed: 26292957
Acta Odontol Scand. 2016;74(3):170-7
pubmed: 26577643
Tumour Biol. 2016 Jul;37(7):9263-71
pubmed: 26779624
Mol Cancer. 2016 Apr 07;15:28
pubmed: 27056547
Clin Oral Investig. 2017 Apr;21(3):937-947
pubmed: 27161218
J Oral Biol Craniofac Res. 2016 Nov;6(Suppl 1):S51-S54
pubmed: 27900251
Acta Otorhinolaryngol Ital. 2017 Apr;37(2):94-101
pubmed: 28516971
Int J Oral Maxillofac Surg. 2018 Jun;47(6):699-707
pubmed: 29174861
J Periodontol. 1993 May;64(5 Suppl):456-60
pubmed: 8315568
Anticancer Res. 1997 Jul-Aug;17(4B):2859-60
pubmed: 9329547